Fairmount Funds Management LLC - Director, 10%+ Owner at Oruka Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director, 10%+ Owner
Issuer Symbol
ORKA on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Fairmount Funds Management LLC since 07 Feb 2025

Holdings reported by Fairmount Funds Management LLC for Oruka Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2,573,308 $37,338,699 $14.51 17 Sep 2025 By Fairmount Healthcare Co-Invest III L.P.
Common Stock 1,131,954 $16,979,310 $15.00 17 Sep 2025 By Fairmount Healthcare Fund II L.P.
Series A Non-Voting Convertible Preferred Stock 0 $0 $23000.00 19 Nov 2024 By Fairmount Healthcare Fund II L.P. Common Stock
Stock Option (Right to Buy) 17,500 02 Jun 2025 By: Peter Harwin Common Stock

Transactions reported by Fairmount Funds Management LLC for Oruka Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.